Semler Scientific Inc (SMLR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Semler Scientific Inc (SMLR) has a cash flow conversion efficiency ratio of -0.072x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-32.95 Million) by net assets ($459.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SMLR market cap overview for the company's overall valuation and market capitalisation.
Semler Scientific Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Semler Scientific Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Semler Scientific Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Semler Scientific Inc ranked by their cash flow conversion efficiency. Explore Semler Scientific Inc cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mayur Uniquoters Ltd
NSE:MAYURUNIQ
|
0.082x |
|
The Star Entertainment Group Limited
F:EE9
|
-0.069x |
|
Advanced Enzyme Technologies Limited
NSE:ADVENZYMES
|
0.038x |
|
Jiangsu Lidao New Material Co Ltd Class A
SHG:603937
|
0.018x |
|
ON24 Inc
NYSE:ONTF
|
-0.008x |
|
EDREAMS ODIGEO UNS.ADR/10
F:K0I
|
0.116x |
|
Fujian Yuanxiang New Materials Co. Ltd. A
SHE:301300
|
N/A |
|
X4 Pharmaceuticals Inc
NASDAQ:XFOR
|
-0.134x |
Annual Cash Flow Conversion Efficiency for Semler Scientific Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Semler Scientific Inc from 2011 to 2024. View Semler Scientific Inc share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $230.75 Million | $24.41 Million | 0.106x | -57.38% |
| 2023-12-31 | $71.80 Million | $17.82 Million | 0.248x | -20.87% |
| 2022-12-31 | $55.68 Million | $17.46 Million | 0.314x | -11.02% |
| 2021-12-31 | $45.55 Million | $16.06 Million | 0.353x | -30.51% |
| 2020-12-31 | $29.79 Million | $15.11 Million | 0.507x | -47.89% |
| 2019-12-31 | $13.07 Million | $12.73 Million | 0.974x | -13.02% |
| 2018-12-31 | $4.20 Million | $4.70 Million | 1.119x | +565.61% |
| 2017-12-31 | $-2.58 Million | $621.00K | -0.240x | -138.90% |
| 2016-12-31 | $-2.92 Million | $-1.80 Million | 0.618x | -83.98% |
| 2015-12-31 | $-1.07 Million | $-4.13 Million | 3.857x | +446.77% |
| 2014-12-31 | $3.44 Million | $-3.82 Million | -1.112x | -127.53% |
| 2013-12-31 | $-295.00K | $-1.19 Million | 4.041x | +693.27% |
| 2012-12-31 | $-3.58 Million | $-1.82 Million | 0.509x | -81.26% |
| 2011-12-31 | $-469.00K | $-1.27 Million | 2.719x | -- |
About Semler Scientific Inc
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardi… Read more